(Q33521786)

27 July 2017

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data (English)

1 reference

27 July 2017

0 references

M Reis

1

0 references

author name string

B Källén

series ordinal

2

1 reference

PubMed ID

20047705

27 July 2017

language of work or name

English

0 references

publication date

5 January 2010

1 reference

27 July 2017

Psychological Medicine

1 reference

27 July 2017

40

1 reference

27 July 2017

1723-1733

1 reference

27 July 2017

10

1 reference

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

27 July 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Neonatal paroxetine withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Risks associated with selective serotonin reuptake inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Antidepressant drugs during pregnancy and infant congenital heart defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Maternal drug use in early pregnancy and infant cardiovascular defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

The safety of antidepressant drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Methodological issues in the epidemiological study of the teratogenicity of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Neonate characteristics after maternal use of antidepressants in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry, 1985-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Delivery outcome after the use of antidepressants in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Selective serotonin reuptake inhibitor use and risk of gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Outcomes of prenatal antidepressant exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Role of anxiety and depression in the onset of spontaneous preterm labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

7 January 2021

Paroxetine in the first trimester and the prevalence of congenital malformations

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

7 January 2021

Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

7 January 2021

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

7 January 2021

Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709992194

7 January 2021

10.1017/S0033291709992194

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

20047705